Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With LOBC and LABC - A Feasibility Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Colecalciferol (Primary) ; Progesterone (Primary) ; Doxorubicin; Epirubicin
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 08 Oct 2020 Biomarkers information updated
- 26 Jun 2013 New source identified and integrated (Clinical Trials Registry - India: CTRI2013-06-003788).
- 18 Jun 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2020 as reported by ClinicalTrials.gov.